Trisha Shetty (Editor)

PF 03550096

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
CAS Number
  
910376-39-5

ChemSpider
  
21378519

3D model (Jmol)
  
Interactive image

PubChem CID
  
24857887

Formula
  
C19H28N4O4

Molar mass
  
376.45 g/mol

PF-03550096 httpsuploadwikimediaorgwikipediacommonsthu

PF-03550096 is a drug that acts as a potent agonist for the CB2 cannabinoid receptor, with good selectivity over CB1 having Ki values of 7nM at CB2 and 1500nM at CB1. It was originally developed by Pfizer in 2008 as a medication for irritable bowel syndrome, but has only progressed to animal studies.

References

PF-03550096 Wikipedia
(Text) CC BY-SA